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2013 Annual Report for the Emerging Infections Program for Clostridium difficile Infection
In 2013, a total of 16,379 cases of C. difficile infection (CDI) were reported to the Emerging Infections Program
(EIP) in 36 counties in 10 US states (California, Colorado, Connecticut, Georgia, Maryland, Minnesota, New
Mexico, New York, Oregon, and Tennessee).
The overall distribution of EIP CDI cases and crude incidence by selected demographic factors and epidemiologic
classification are presented in Table 1. Data in this report are not intended to be directly compared to annual
reports from other years, and should not be used to determine annual changes in EIP CDI incidence rates
because single year calculations do not account for changes in testing practices by reporting facilities.
Table 1. Reported Number of CDI Cases and Crude Incidence by Sex, Age Group, Race, and Epidemiologic
Classification Among the 10 EIP Sitesa 
Demographic
Characteristic
Population ≥1
Year of Age
Community Associated
CDIb
Healthcare Associated
CDIb
All CDI
No. Incidencec No. Incidencec No. Incidencec 
Sex
Male 5663849 2401 42.39 4308 76.06 6709 118.45
Female 5889106 4040 68.60 5630 95.60 9670 164.20
Age group
1-17 years 2546460 494 19.40 193 7.58 687 26.98
18-44 years 4549306 1592 34.99 983 21.61 2575 56.60
45-64 years 3040854 2063 67.84 2546 83.73 4609 151.57
≥65 years 1416335 2292 161.83 6216 438.88 8508 600.71
Race 
White 8033940 5255 65.41 7611 94.74 12866 160.15
Non-white 3519015 1186 33.70 2327 66.13 3513 99.83
Total 11552955 6441 55.75 9938 86.02 16379 141.77
a The epidemiologic classification was statistically imputed for 0.6% of the observed CDI cases, and race was
statistically imputed for 21.8% of the observed CDI cases. The weighted frequency of cases in Colorado and
Georgia were based on 33% random sampling.
b A CDI case was classified as community-associated if the C. difficile-positive stool specimen was collected on an
outpatient basis or within 3 days after hospital admission in a person with no documented overnight stay in a 
healthcare facility in the preceding 12 weeks. All CDI cases that do not meet the aforementioned criteria were
classified as healthcare-associated.
c Cases per 100,000 persons.
Laboratory Characterization of C. difficile Isolates
In 2013, a total of 1,228 C. difficile isolates were submitted to CDC for further analysis. The total number of 
isolates received from each site ranged from 49 to 274, with a median of 94.5. The majority of the isolates (95%)
were collected in metropolitan areas.
Among all available isolates, 146 distinct ribotypes were detected. Ribotypes 027, 106, 020, 002 and 014 were
the most common observed in both community- and healthcare-associated C. difficile isolates (Tables 2 and 3). A
significant decrease in ribotype 027 occurred from 17% in 2012 to 12% in 2013 among community-associated C.
difficile isolates.
                
          
      
      
      
   
   
   
   
   
   
   
   
   
   
   
      
      
      
   
   
   
   
   
   
   
   
   
   
   
Twenty-nine percent of the isolates harbored a deletion in tcdC. Twenty-nine percent of the isolates were binary
toxin-positive, and among these, ribotypes 027, 078 and 019 predominated.
Table 2. Frequency of Ribotypes Among Community- Table 3. Frequency of Ribotypes Among Healthcare-
Associated C. difficile Isolates, 2013 (n=689) Associated C. difficile Isolates, 2013 (n=539)
Ribotype No of isolates % isolates
027 82 12%
106 65 9%
020 54 8%
002 52 8%
014 33 5%
078 23 3%
076 21 3%
015 21 3%
001_072 19 3%
056 18 3%
Others 301 44%
Ribotype No of isolates % isolates
027 128 24%
106 43 8%
014 37 7%
002 29 5%
020 29 5%
017 15 3%
005 14 3%
056 14 3%
001_072 14 3%
078 11 2%
Others 205 38%
